July 14, 2020

Volume X, Number 196

July 14, 2020

Subscribe to Latest Legal News and Analysis

July 13, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
8
Nov
Admissions of Drug Use By Employees Are Not The Same As Positive Test Results in Minnesota Jackson Lewis P.C.
7
Nov
November Elections Impact the Food & Beverage Industry (Part 1) Mintz
6
Nov
CMS Finalizes OPPS Rule Packaging Pathology Services Ordered for Hospital Outpatients Mintz
6
Nov
Sunshine Act ‘Open Payments’ Database Sheds Dim Light on Transparency Faegre Drinker
6
Nov
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 2 of a 5-Part Series Michael Best & Friedrich LLP
5
Nov
Recent Trends in Medical Device Patent Litigation at the ITC: Part 2 Covington & Burling LLP
5
Nov
Genetic Technologies v. Bristol Myers – 101 At Work Schwegman, Lundberg & Woessner, P.A.
5
Nov
Florida’s Medical Marijuana Amendment Defeated, but Zoning Issues Loom for Charlotte’s Web Law Bilzin Sumberg
5
Nov
Custom Device Exemption Remains Narrow, but FDA’s Final Guidance Addresses Industry Concern About “Device Type” Definition Covington & Burling LLP
5
Nov
Oregon, Alaska and D.C. Legalize Recreational Marijuana Jackson Lewis P.C.
4
Nov
Lawful Waffle: California Courts Dismiss “Natural” Food False Ad Claims Proskauer Rose LLP
4
Nov
Wisconsin Court of Appeals Holds That Alleged Incorporation Of Wrong Ingredient Constitutes Property Damage Caused By An Occurrence von Briesen & Roper, s.c.
4
Nov
Mobile Health Apps are in a Boom Phase – Why is it so Hard for Pharmaceutical Companies to Find Users? Sheppard, Mullin, Richter & Hampton LLP
4
Nov
The Era of Generic Biologic Drugs Has Officially Begun: An Update on U.S. Biosimilars [VIDEO] Sterne, Kessler, Goldstein & Fox P.L.L.C.
4
Nov
PTAB Adopts Broad View of Inherency Doctrine McDermott Will & Emery
3
Nov
Device and Food Firms Take Note: FDA Asserts Final Guidance on Delaying, Denying, Limiting, or Refusing to Permit Inspection Applies to You Too Barnes & Thornburg LLP
3
Nov
Canadian Hospital To Travel The Long And Winding Road Of “Gene Patenting” Schwegman, Lundberg & Woessner, P.A.
3
Nov
Agricultural Cooperative Antitrust Litigation Continues to Mushroom Sheppard, Mullin, Richter & Hampton LLP
3
Nov
Beginning to Close the POM Circle? – POM Wonderful and Drug Advertising: JHP Pharmaceuticals Sheppard, Mullin, Richter & Hampton LLP
2
Nov
Ghana Achieves “Zero Hunger” Covington & Burling LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS